مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

170
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

174
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

The Efficacy of N-acetilcysteine for the Treatment of the Metamfetamin-addicted Patients Under Methadon Therapy: A Double-blind Clinical Trial

Pages

  0-0

Abstract

 Background: Methamphetamine dependence is a growing global problem. Currently, there are no approved pharmacotherapy options for the management of Methamphetamine dependence. One of the alternatives to manage this addiction is the use of N acetylcysteine (NAC) due to its capacity to restore homeostasis in the brain glutamate systems disrupted in addiction and its ability to reduce Craving and the risk of relapse. Methods: Methamphetamine-dependentvolunteersunderMethadonetreatment (n=38)wererandomizedto receive daily doses of 1200 mgof NAC, or placebo. The participants were followed for 12 weeks (two visits weekly). Craving and Beck Inventory Depression (BDI) was determined at the beginning of the study and also after one month, two months, and three months. Addiction severity index (ASI) was recorded at the beginning of the study and after three months. The data were analyzed via SPSS version 16. 0 (SPSS Inc. Chicago, Illinios, USA) Results: The mean score of Craving and BDI reduced after two months with NAC treatment. ASI (e. g., substance, familial, and psychiatric categories) was significantly reduced at the end of the study in the NAC group compared to placebo (P < 0. 001). The success of the treatment in groups of NAC and placebo were 84% and 73%, respectively (P = 0. 001). 63. 2% of the NAC group patients avoided substance use for more than a month, but this was 10. 5% in the placebo group (P = 0. 001). Conclusions: The NAC showed good efficacy in suppressing Methamphetamine Craving, addiction severity index, and depression. It may be a useful pharmacological treatment for Methamphetamine Dependency.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    Karami, Farzaneh, ASSARIAN, FATEMEH, GHOREISHI, FATEMEH SADAT, & SEHAT, MOJTABA. (2020). The Efficacy of N-acetilcysteine for the Treatment of the Metamfetamin-addicted Patients Under Methadon Therapy: A Double-blind Clinical Trial. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), 22(7), 0-0. SID. https://sid.ir/paper/764205/en

    Vancouver: Copy

    Karami Farzaneh, ASSARIAN FATEMEH, GHOREISHI FATEMEH SADAT, SEHAT MOJTABA. The Efficacy of N-acetilcysteine for the Treatment of the Metamfetamin-addicted Patients Under Methadon Therapy: A Double-blind Clinical Trial. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ)[Internet]. 2020;22(7):0-0. Available from: https://sid.ir/paper/764205/en

    IEEE: Copy

    Farzaneh Karami, FATEMEH ASSARIAN, FATEMEH SADAT GHOREISHI, and MOJTABA SEHAT, “The Efficacy of N-acetilcysteine for the Treatment of the Metamfetamin-addicted Patients Under Methadon Therapy: A Double-blind Clinical Trial,” IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), vol. 22, no. 7, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/764205/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button